Cleared Traditional

K895791 - OXYMAX

K895791 is an FDA 510(k) clearance for OXYMAX, manufactured by Columbus Instruments Intl. Corp.. The device is a Class 2 Anesthesiology device with product code BZL cleared through the Traditional 510(k) pathway after a 181-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1990
Decision
181d
Days
Class 2
Risk

K895791 is an FDA 510(k) clearance for the OXYMAX. Classified as Computer, Oxygen-uptake (product code BZL), Class II - Special Controls.

Submitted by Columbus Instruments Intl. Corp. (Columbus, US). The FDA issued a Cleared decision on March 28, 1990 after a review of 181 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1730 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K895791

510(k) Number K895791 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 1989
Decision Date March 28, 1990
Days to Decision 181 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 140d · This submission: 181d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BZL Device Classification - Class 2, Special Controls

Product Code BZL Computer, Oxygen-uptake
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZL Computer, Oxygen-uptake

All 32
Devices cleared under the same product code (BZL) and FDA review panel - the closest regulatory comparables to K895791.
DELTATRAC(TM) II METABOLIC MONITOR
K931422 · Datex Division Instrumentarium Corp. · Nov 1993
PHYSIO-DYNE EASI - LAB
K922660 · Physio-Dyne · Apr 1993
MEDGRAPHICS PF/DX
K912906 · Medical Graphics Corp. · Feb 1992
ICOR CMU Q PLUS
K895935 · Icor AB · Jan 1990
VVR/Q CALORIMETER
K895586 · Vita-Stat · Sep 1989
MOXUS OR OCM-1 OXYGEN UPTAKE SYSTEM
K874663 · Ametek/Thermox Instruments Division · May 1988